FR2012964A1 - - Google Patents

Info

Publication number
FR2012964A1
FR2012964A1 FR6923465A FR6923465A FR2012964A1 FR 2012964 A1 FR2012964 A1 FR 2012964A1 FR 6923465 A FR6923465 A FR 6923465A FR 6923465 A FR6923465 A FR 6923465A FR 2012964 A1 FR2012964 A1 FR 2012964A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6923465A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOGERAS
Original Assignee
SOGERAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOGERAS filed Critical SOGERAS
Publication of FR2012964A1 publication Critical patent/FR2012964A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01B—MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
    • G01B13/00—Measuring arrangements characterised by the use of fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR6923465A 1968-07-15 1969-07-10 Withdrawn FR2012964A1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33654/68A GB1219606A (en) 1968-07-15 1968-07-15 Quinuclidinol derivatives and preparation thereof

Publications (1)

Publication Number Publication Date
FR2012964A1 true FR2012964A1 (OSRAM) 1970-03-27

Family

ID=10355712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6923465A Withdrawn FR2012964A1 (OSRAM) 1968-07-15 1969-07-10

Country Status (9)

Country Link
US (1) US3714357A (OSRAM)
AT (1) AT291272B (OSRAM)
BE (1) BE735031A (OSRAM)
CH (1) CH513174A (OSRAM)
DE (1) DE1935751A1 (OSRAM)
FR (1) FR2012964A1 (OSRAM)
GB (1) GB1219606A (OSRAM)
NL (1) NL148607B (OSRAM)
SE (1) SE361314B (OSRAM)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2155927A1 (en) * 1971-10-15 1973-05-25 Synthelabo 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
WO2001004118A3 (en) * 1999-07-14 2001-07-19 Almirall Prodesfarma Sa Quinuclidine derivatives and their use as muscarinic m3 receptor ligands
US7122558B2 (en) 2000-12-28 2006-10-17 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
US7208501B2 (en) 2000-12-22 2007-04-24 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
US7435742B2 (en) 2002-06-21 2008-10-14 Laboratorios Almirall S.A. Quinuclidine derivatives and pharmaceutical compositions containing the same
US7488735B2 (en) 2002-07-02 2009-02-10 Laboratorios Almirall S.A. Quinuclidine amide derivatives
US8044205B2 (en) 2006-07-21 2011-10-25 Laboratorios Almirall, S.A. Process for manufacturing 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide
US8084463B2 (en) 2004-11-02 2011-12-27 Novartis Ag Quinuclidine derivatives and their use as muscarinic M3 receptor antagonists
WO2015007073A1 (zh) 2013-07-13 2015-01-22 北京市丰硕维康技术开发有限责任公司 奎宁类化合物、其光学异构体及其制备方法和医药用途
US9254262B2 (en) 2008-03-13 2016-02-09 Almirall, S.A. Dosage and formulation
US9737520B2 (en) 2011-04-15 2017-08-22 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US10085974B2 (en) 2008-03-13 2018-10-02 Almirall, S.A. Dosage and formulation

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1130997B (it) * 1980-03-19 1986-06-18 D & D Srl Esteri e derivati chinucleidinici di acidi fenossicarbossilici,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4431627A (en) * 1980-06-03 1984-02-14 Research Corporation Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; methods of preparation thereof and imaging and assay methods utilizing same
WO1981003422A1 (en) * 1980-06-03 1981-12-10 Research Corp Gamma-emitting receptor-binding quinuclidinyl benzilates;methods of preparation thereof and imaging and assay methods utilizing same
US4644003A (en) * 1985-04-03 1987-02-17 Research Corporation 3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
JPH0725756B2 (ja) * 1990-09-06 1995-03-22 ファイザー・インコーポレーテッド 抗ムスカリン性気管支拡張剤
EP0938313A4 (en) * 1996-07-01 2000-02-23 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATING URINE CONTINENCE BY ENANTOMERICALLY ENRICHED (S) CLIDINUM
EP0957916A4 (en) * 1996-07-01 2000-02-23 Sepracor Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINE INCONTINENCE BY means of (R) CLIDINIUM ENRICHED BY ENANTIONMORPHISM
ES2206021B1 (es) * 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
TW200519106A (en) 2003-05-02 2005-06-16 Novartis Ag Organic compounds
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
CA2625664C (en) 2005-10-21 2016-01-05 Novartis Ag Human antibodies against il13 and therapeutic uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
HRP20120494T1 (hr) 2006-04-21 2012-08-31 Novartis Ag Derivati purina za uporabu kao agonista adenozin a2a receptora
CN101516885A (zh) 2006-09-29 2009-08-26 诺瓦提斯公司 作为pi3k脂质激酶抑制剂的吡唑并嘧啶类化合物
NZ577939A (en) 2007-01-10 2011-03-31 Irm Llc Compounds and compositions as channel activating protease inhibitors
KR20100005730A (ko) 2007-05-07 2010-01-15 노파르티스 아게 유기 화합물
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
EA017919B1 (ru) 2007-12-10 2013-04-30 Новартис Аг Производные пиразин-2-карбоксамида для лечения заболеваний, которые поддаются лечению путем блокирования эпителиальных натриевых каналов
PT2231642E (pt) 2008-01-11 2014-03-12 Novartis Ag Pirimidinas como inibidores de quinase
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
US8236808B2 (en) 2008-06-10 2012-08-07 Novartis Ag Pyrazine derivatives as ENAC blockers
WO2010088335A1 (en) 2009-01-29 2010-08-05 Novartis Ag Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EP2464649A1 (en) 2009-08-12 2012-06-20 Novartis AG Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
DK2467141T3 (en) 2009-08-17 2019-02-18 Intellikine Llc HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
BR112012008061A2 (pt) 2009-08-20 2016-03-01 Novartis Ag compostos de oxima heterocíclica
WO2011050325A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
JP2014505088A (ja) 2011-02-10 2014-02-27 ノバルティス アーゲー Ｃ−ＭＥＴチロシンキナーゼ阻害剤としての［１，２，４］トリアゾロ［４，３−ｂ］ピリダジン化合物
EP2678016B1 (en) 2011-02-23 2016-08-10 Intellikine, LLC Heterocyclic compounds and uses thereof
PH12013501758A1 (en) 2011-02-25 2013-10-14 Irm Llc Pyrazolo [1,5-a] pyridines as trk inhibitors
UY34305A (es) 2011-09-01 2013-04-30 Novartis Ag Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
MX339302B (es) 2011-09-15 2016-05-19 Novartis Ag 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
ES2558457T3 (es) 2011-09-16 2016-02-04 Novartis Ag Compuestos heterocíclicos para el tratamiento de fibrosis quística
EP2755652B1 (en) 2011-09-16 2021-06-02 Novartis AG N-substituted heterocyclyl carboxamides
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
JP6130391B2 (ja) 2011-11-23 2017-05-17 インテリカイン， エルエルシー Ｍｔｏｒ阻害剤を使用する強化された治療レジメン
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
EP3964513A1 (en) 2012-04-03 2022-03-09 Novartis AG Combination products with tyrosine kinase inhibitors and their use
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
JP2016512835A (ja) 2013-03-15 2016-05-09 インテリカイン， エルエルシー キナーゼ阻害剤の組み合わせ及びそれらの使用
WO2015084804A1 (en) 2013-12-03 2015-06-11 Novartis Ag Combination of mdm2 inhibitor and braf inhibitor and their use
JP6433509B2 (ja) 2014-04-24 2018-12-05 ノバルティス アーゲー ホスファチジルイノシトール３−キナーゼ阻害薬としてのアミノピラジン誘導体
BR112016023967A2 (pt) 2014-04-24 2017-08-15 Novartis Ag derivados de pirazina como inibidores de fosfatidilinositol 3-cinase
EP3134396B1 (en) 2014-04-24 2019-09-18 Novartis AG Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
WO2016011658A1 (en) 2014-07-25 2016-01-28 Novartis Ag Combination therapy
CA2954862A1 (en) 2014-07-31 2016-02-04 Novartis Ag Combination therapy
EP3980121A1 (en) 2019-06-10 2022-04-13 Novartis AG Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
AU2020338971B2 (en) 2019-08-28 2023-11-23 Novartis Ag Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3252981A (en) * 1963-05-24 1966-05-24 Chemetron Corp Process for benzilic esters

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3252981A (en) * 1963-05-24 1966-05-24 Chemetron Corp Process for benzilic esters

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2155927A1 (en) * 1971-10-15 1973-05-25 Synthelabo 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
US10034867B2 (en) 1999-07-14 2018-07-31 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
JP2005350476A (ja) * 1999-07-14 2005-12-22 Almirall Prodesfarma Ag キヌクリジン誘導体およびそれらのムスカリンｍ３レセプターリガンドとしての使用
US7078412B2 (en) 1999-07-14 2006-07-18 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
US7109210B2 (en) 1999-07-14 2006-09-19 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
US10588895B2 (en) 1999-07-14 2020-03-17 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7196098B2 (en) 1999-07-14 2007-03-27 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
BG65565B1 (bg) * 1999-07-14 2008-12-30 Almirall Prodesfarma, S.A. Хинуклидинови производни и тяхното използване като мускаринови м3 рецепторни лиганди
US8129405B2 (en) 1999-07-14 2012-03-06 Almirall Prodesfarma S.A. Quinuclidine derivatives and medicinal compositions containing the same
WO2001004118A3 (en) * 1999-07-14 2001-07-19 Almirall Prodesfarma Sa Quinuclidine derivatives and their use as muscarinic m3 receptor ligands
US6750226B2 (en) 1999-07-14 2004-06-15 Almirall-Prodesfarma, S.A. Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
US8513279B2 (en) 1999-07-14 2013-08-20 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
CZ304292B6 (cs) * 1999-07-14 2014-02-19 Almirall, S.A. Chinuklidinové deriváty, způsob jejich přípravy a použití a farmaceutická kompozice s jejich obsahem
US9687478B2 (en) 1999-07-14 2017-06-27 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
USRE46417E1 (en) 1999-07-14 2017-05-30 Almirall, S.A. Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
US9333195B2 (en) 1999-07-14 2016-05-10 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7750023B2 (en) 1999-07-14 2010-07-06 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7897617B2 (en) 1999-07-14 2011-03-01 Almirall Prodesfarma S.A. Quinuclidine derivatives and medicinal compositions containing the same
US9056100B2 (en) 1999-07-14 2015-06-16 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US8802699B2 (en) 1999-07-14 2014-08-12 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7776879B2 (en) 2000-12-22 2010-08-17 Almirall, S.A. Quinuclidine carbamate derivatives and their use as M3 antagonists
US7208501B2 (en) 2000-12-22 2007-04-24 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
US7312231B2 (en) 2000-12-22 2007-12-25 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
AU2002238471B2 (en) * 2000-12-28 2007-06-28 Almirall, S.A. Quinuclidine derivatives and their use as M3 antagonists
CZ301209B6 (cs) * 2000-12-28 2009-12-09 Laboratorios Almirall, S.A. Nové chinuklidinové deriváty a medicinální kompozice s jejich obsahem
US7122558B2 (en) 2000-12-28 2006-10-17 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
BG66162B1 (bg) * 2000-12-28 2011-09-30 Almirall Prodesfarma Ag Хинуклидинови производни и медицински състави, които ги съдържат
US7893087B2 (en) 2000-12-28 2011-02-22 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7879874B2 (en) 2000-12-28 2011-02-01 Almirall, S.A. Quinuclidine derivatives and medicinal compositions containing the same
US7435742B2 (en) 2002-06-21 2008-10-14 Laboratorios Almirall S.A. Quinuclidine derivatives and pharmaceutical compositions containing the same
US7488735B2 (en) 2002-07-02 2009-02-10 Laboratorios Almirall S.A. Quinuclidine amide derivatives
US7718670B2 (en) 2002-07-02 2010-05-18 Laboratorios Almirall S.A Quinuclidine amide derivatives
US8084463B2 (en) 2004-11-02 2011-12-27 Novartis Ag Quinuclidine derivatives and their use as muscarinic M3 receptor antagonists
US8044205B2 (en) 2006-07-21 2011-10-25 Laboratorios Almirall, S.A. Process for manufacturing 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide
US9254262B2 (en) 2008-03-13 2016-02-09 Almirall, S.A. Dosage and formulation
US10085974B2 (en) 2008-03-13 2018-10-02 Almirall, S.A. Dosage and formulation
US11000517B2 (en) 2008-03-13 2021-05-11 Almirall, S.A. Dosage and formulation
US9737520B2 (en) 2011-04-15 2017-08-22 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2015007073A1 (zh) 2013-07-13 2015-01-22 北京市丰硕维康技术开发有限责任公司 奎宁类化合物、其光学异构体及其制备方法和医药用途

Also Published As

Publication number Publication date
CH513174A (fr) 1971-09-30
SE361314B (OSRAM) 1973-10-29
NL148607B (nl) 1976-02-16
GB1219606A (en) 1971-01-20
DE1935751A1 (de) 1970-02-26
NL6910859A (OSRAM) 1970-01-19
BE735031A (OSRAM) 1969-12-01
US3714357A (en) 1973-01-30
AT291272B (de) 1971-07-12

Similar Documents

Publication Publication Date Title
AU1946070A (OSRAM)
AU428130B2 (OSRAM)
AU2374870A (OSRAM)
AU5184069A (OSRAM)
AU6168869A (OSRAM)
AU6171569A (OSRAM)
AU416157B2 (OSRAM)
AU429879B2 (OSRAM)
AU2581067A (OSRAM)
AU4811568A (OSRAM)
AU421558B1 (OSRAM)
AU3224368A (OSRAM)
AU3789668A (OSRAM)
AU4744468A (OSRAM)
AU2580267A (OSRAM)
AU479393A (OSRAM)
BE708933A (OSRAM)
AU4558658A (OSRAM)
AU463027A (OSRAM)
AU4464266A (OSRAM)
BE708888A (OSRAM)
AU479894A (OSRAM)
AU4270368A (OSRAM)
AU4224469A (OSRAM)
AU3083868A (OSRAM)

Legal Events

Date Code Title Description
CD Change of name or company name
CD Change of name or company name
TP Transmission of property
ST Notification of lapse